Related Experiment Video
Updated: Mar 17, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
[ANALYSIS OF MICROFLORA OF PLEURAL CAVITY IN PLEURAL EMPYEMA]
Abstract:
In the pleural empyema (PE) treatment, not depending on introduction of multiple operative procedures and the medicinal preparations application, some issues remain unsolved, including the infection agents verification, the most rapid bronchial fistula elimination and the lung volume restoration. The EP infection agents spectrum, their sensitivity to preparations were revealed, as well as the enhanced rate of the methicillin-resistant stamms (MRSA) and the microorganisms associations verification. A reduction of the infection agents sensitivity towards "simple" antibacterial preparations was established, so the physicians, treating PE, must prescribe "hard" antibiotics, what enhances its cost.
Insights
Pleural empyema (PE) treatment faces challenges in identifying pathogens and restoring lung function. Increased resistance to common antibiotics necessitates the use of more potent, costly drugs for effective PE management.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Context:
- Pleural empyema (PE) treatment remains complex despite advances in surgical and medical interventions.
- Key challenges include accurate pathogen identification, rapid bronchial fistula closure, and lung volume restoration.
Purpose:
- To analyze the spectrum of infectious agents in pleural empyema.
- To assess the sensitivity of these agents to various antimicrobial preparations.
- To identify trends in antibiotic resistance, including methicillin-resistant Staphylococcus aureus (MRSA).
Summary:
- The study identified the spectrum of infectious agents responsible for PE and their susceptibility patterns.
- A significant increase in methicillin-resistant Staphylococcus aureus (MRSA) and microbial associations was observed.
- Reduced sensitivity of causative agents to standard antibiotics was confirmed, indicating a need for advanced antimicrobial agents.
Impact:
- Findings highlight the challenges in treating PE due to evolving microbial resistance.
- The reduced efficacy of common antibiotics necessitates the use of broader-spectrum, more expensive 'hard' antibiotics.
- This shift impacts treatment costs and underscores the need for updated therapeutic guidelines for PE.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Pleura of the Lungs

